Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] VCL is engaged in the business of distribution and supply of healthcare, personal care and other FMCG products. While marking growth for the reported period in its earnings, boosted performance for FY25 is a bit surprising. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears fully priced. Well-informed/cash surplus investors may park moderate funds for long term. Read detail review...
Vijaypd Ceutical Ltd. peer comparison with similar listed entities. (As on March 31, 2025)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Vijaypd Ceutical Limited | 3.84 | 3.84 | 25.78 | 9.11 | 14.91 | 1.40 | |
| MedPlus Health Services Limited | 3.37 | 3.37 | 103.63 | 249.42 | 3.32 | 8.16 | |
| Entero Healthcare Solutions Limited | 4.41 | 4.41 | 379.33 | 256.17 | 1.17 | 2.98 |
Notes:
Vijaypd Ceutical IPO Reviews, analysis and views by popular members. Read Vijaypd Ceutical Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
DRHP